
Mina Haghighatian
Examiner (ID: 3468, Phone: (571)272-0615 , Office: P/1616 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1619, 1616 |
| Total Applications | 1626 |
| Issued Applications | 770 |
| Pending Applications | 183 |
| Abandoned Applications | 682 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17958523
[patent_doc_number] => 20220339103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => Lung-targeted corticosteroid treatment in viral respiratory disease, COVID-19 and ARDS (acute respiratory distress syndrome)
[patent_app_type] => utility
[patent_app_number] => 17/724474
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724474 | Lung-targeted corticosteroid treatment in viral respiratory disease, COVID-19 and ARDS (acute respiratory distress syndrome) | Apr 18, 2022 | Abandoned |
Array
(
[id] => 19186348
[patent_doc_number] => 20240165261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MEANS AND METHOD FOR CYTOSOLIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/552838
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552838
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552838 | MEANS AND METHOD FOR CYTOSOLIC DELIVERY | Mar 27, 2022 | Pending |
Array
(
[id] => 18969612
[patent_doc_number] => 20240049704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => Emulsion
[patent_app_type] => utility
[patent_app_number] => 18/552171
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552171 | Emulsion | Mar 22, 2022 | Pending |
Array
(
[id] => 19613303
[patent_doc_number] => 20240398983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/282699
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282699
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282699 | POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF | Mar 21, 2022 | Abandoned |
Array
(
[id] => 17759912
[patent_doc_number] => 20220233524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/699405
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699405 | LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF | Mar 20, 2022 | Abandoned |
Array
(
[id] => 20083533
[patent_doc_number] => 20250213469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => DOSAGE FORMS OF ACTIVE SUBSTANCES USED AGAINST VIRAL DISEASES IN DRY POWDER INHALER DEVICE FOR SYMPTOMS CAUSED BY COVID-19 AND OTHER VIRAL LUNG DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/848271
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18848271
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/848271 | DOSAGE FORMS OF ACTIVE SUBSTANCES USED AGAINST VIRAL DISEASES IN DRY POWDER INHALER DEVICE FOR SYMPTOMS CAUSED BY COVID-19 AND OTHER VIRAL LUNG DISEASES | Mar 17, 2022 | Pending |
Array
(
[id] => 18647666
[patent_doc_number] => 20230293436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Inhalable dry powder pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 17/695155
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695155 | Inhalable dry powder pharmaceutical composition | Mar 14, 2022 | Abandoned |
Array
(
[id] => 18625846
[patent_doc_number] => 20230284625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD FOR CULTIVATING CITRUS PLANT
[patent_app_type] => utility
[patent_app_number] => 17/694056
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694056 | METHOD FOR CULTIVATING CITRUS PLANT | Mar 13, 2022 | Abandoned |
Array
(
[id] => 18625847
[patent_doc_number] => 20230284626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD FOR CULTIVATING CITRUS PLANT AND LIQUID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/694101
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694101 | METHOD FOR CULTIVATING CITRUS PLANT AND LIQUID COMPOSITION | Mar 13, 2022 | Abandoned |
Array
(
[id] => 17670913
[patent_doc_number] => 20220184080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/685704
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685704
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685704 | NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Mar 2, 2022 | Pending |
Array
(
[id] => 19423811
[patent_doc_number] => 12083202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Lipophilic cosmetic compositions containing pelargonic acid esters
[patent_app_type] => utility
[patent_app_number] => 17/590051
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6466
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590051 | Lipophilic cosmetic compositions containing pelargonic acid esters | Jan 31, 2022 | Issued |
Array
(
[id] => 17575993
[patent_doc_number] => 20220132848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => HERBICIDAL COMBINATION
[patent_app_type] => utility
[patent_app_number] => 17/574052
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574052 | HERBICIDAL COMBINATION | Jan 11, 2022 | Abandoned |
Array
(
[id] => 20192110
[patent_doc_number] => 20250268820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => METHOD FOR MANUFACTURING AN INHALABLE POWDER COMPRISING VORICONAZOLE
[patent_app_type] => utility
[patent_app_number] => 18/265463
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265463
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265463 | METHOD FOR MANUFACTURING AN INHALABLE POWDER COMPRISING VORICONAZOLE | Dec 9, 2021 | Pending |
Array
(
[id] => 17503311
[patent_doc_number] => 20220096413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHOD OF USING COMPOSITION FOR TREATMENT OF VEISALGIA
[patent_app_type] => utility
[patent_app_number] => 17/547635
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547635 | METHOD OF USING COMPOSITION FOR TREATMENT OF VEISALGIA | Dec 9, 2021 | Abandoned |
Array
(
[id] => 17480433
[patent_doc_number] => 20220087937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => AEROSOL TYROSINE KINASE INHIBITOR COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/542262
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542262 | AEROSOL TYROSINE KINASE INHIBITOR COMPOUNDS AND USES THEREOF | Dec 2, 2021 | Pending |
Array
(
[id] => 18852742
[patent_doc_number] => 11850294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Buffered microencapsulated compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/456271
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20084
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17456271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/456271 | Buffered microencapsulated compositions and methods | Nov 22, 2021 | Issued |
Array
(
[id] => 17609746
[patent_doc_number] => 20220152025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => INHALED IMATINIB FOR PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/528011
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528011 | INHALED IMATINIB FOR PULMONARY HYPERTENSION | Nov 15, 2021 | Abandoned |
Array
(
[id] => 18732521
[patent_doc_number] => 11801239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/523229
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4717
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523229 | Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor | Nov 9, 2021 | Issued |
Array
(
[id] => 17881082
[patent_doc_number] => 20220296559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
[patent_app_type] => utility
[patent_app_number] => 17/517157
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517157 | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) | Nov 1, 2021 | Abandoned |
Array
(
[id] => 17383027
[patent_doc_number] => 20220030879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Methods and Compositions for Spray Drying Gram-Negative Bacteria
[patent_app_type] => utility
[patent_app_number] => 17/506190
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506190 | Methods and Compositions for Spray Drying Gram-Negative Bacteria | Oct 19, 2021 | Abandoned |